30 September 2026
Buy now, pay later credit can now cover GLP-1 weight-loss drugs in SA, as Obiflex offers instalments for treatments costing R2,500–R6,000.
8 September 2026
Aspen Pharmacare earnings rose 22% as demand for Eli Lilly's weight-loss drug Mounjaro surged, with the group also eyeing generic semaglutide.
16 July 2026
Illicit medicines in South Africa are rising, prompting Sahpra to launch a national campaign on counterfeit drugs and unsafe online sellers.
13 July 2026
Telehealth GLP-1 prescribing practices may expose patients to unsafe care, weak medical checks and compounded weight-loss drugs.
5 November 2025
Aspen's Mounjaro expansion plans promise to enhance diabetes and weight management treatment in Sub-Saharan Africa soon.
12 August 2025
Explore the Ozempic Paradox: discover how weight-loss drugs impact overall healthcare costs despite health improvements.